Physician profile
Manfred Obi
NPI 1467634360
$1,087.81
in general payments reported to CMS, 2019-2025
16 companies · $421 in 2025
The $421 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $67.75 · 2021: $92.33 · 2022: $85.66 · 2023: $112 · 2024: $310 · 2025: $421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $731 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.58 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $284.05 | 2021-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $137.00 | 2021-2025 | Caplyta |
| Teva Pharmaceuticals USA, INC. | $111.49 | 2024 | |
| Supernus Pharmaceuticals, INC. | $106.91 | 2021-2025 | Qelbree, Qelbree |
| E.R. Squibb & Sons, L.L.C. | $101.17 | 2024-2025 | Cobenfy |
| Sunovion Pharmaceuticals INC. | $91.35 | 2020-2022 | |
| Axsome Therapeutics, INC. | $56.02 | 2023-2024 | Sunosi |
| Otsuka America Pharmaceutical, INC. | $42.56 | 2023-2025 | Rexulti, Nuedexta |
| Takeda Pharmaceuticals U.S.A., INC. | $37.80 | 2022-2025 | Trintellix |
| Lundbeck LLC | $31.23 | 2024-2025 | Rexulti |
| Vanda Pharmaceuticals INC. | $17.90 | 2025 | Fanapt |
| Bausch Health US, LLC | $15.61 | 2025 | Aplenzin |
| Ironshore Pharmaceuticals INC. | $15.03 | 2024 | |
| Neos Therapeutics, Lp | $14.36 | 2025 | Adzenys Xr-Odt |
| Avanir Pharmaceuticals, INC. | $13.33 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Noven Therapeutics, LLC | $12.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manfred Obi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.